ClinVar Miner

Submissions for variant NM_020778.5(ALPK3):c.1688T>G (p.Met563Arg)

dbSNP: rs150028343
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000423131 SCV000535204 uncertain significance not provided 2024-04-16 criteria provided, single submitter clinical testing Reported in an individual with ARVC who also harbored a variant in the DSP gene (PMID: 38204539); In silico analysis indicates that this missense variant does not alter protein structure/function; Also known as p.(M765R); This variant is associated with the following publications: (PMID: 38204539)
Labcorp Genetics (formerly Invitae), Labcorp RCV000423131 SCV002199260 uncertain significance not provided 2025-01-23 criteria provided, single submitter clinical testing This sequence change replaces methionine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 765 of the ALPK3 protein (p.Met765Arg). This variant is present in population databases (rs150028343, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with ALPK3-related conditions. ClinVar contains an entry for this variant (Variation ID: 392012). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt ALPK3 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002451048 SCV002738112 likely benign Cardiovascular phenotype 2024-04-19 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute RCV005404569 SCV006070214 likely benign not specified 2025-04-09 criteria provided, single submitter clinical testing BP1, BP4
Clinical Genetics, Academic Medical Center RCV000423131 SCV001925705 uncertain significance not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000423131 SCV001976053 uncertain significance not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.